Advanced BioMedical Technologies, Inc. (ABMT)
- Previous Close
0.0006 - Open
0.0005 - Bid --
- Ask --
- Day's Range
0.0006 - 0.0006 - 52 Week Range
0.0005 - 0.0929 - Volume
1 - Avg. Volume
653 - Market Cap (intraday)
2.809M - Beta (5Y Monthly) -0.33
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.
abtlafleur.comRelated News
Performance Overview: ABMT
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ABMT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ABMT
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
25.57
Enterprise Value/EBITDA
-7.88
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-78.11%
Return on Equity (ttm)
--
Revenue (ttm)
109.84k
Net Income Avi to Common (ttm)
-753.18k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
6.98k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
428.31k
Company Insights: ABMT
ABMT does not have Company Insights